"A Multicenter, Prospective Survey to Evalutate Purulent, Lower Respitory TractExacerbations in the Outpatient Setting."
Study Z0556n, Genetech, Incorporated, August 1993
"Prospectivee, Controlled, Third Party-Blind, Randomized Study
Comparing the Efficacy and Safety of IV/PO Ciproflaxin (400/500 mg Q 12H) with
Parenternal IV or IM Ceftriaxone (1000 mg Q 24H) in the Treatment of Patients with
Pneumonia (Multi-Center)." Study D89-027, Miles, Inc., Pharmaceutical Division, November 1990.
Drug-Study Nurse Coordinator.
"Prospectivee, Controlled, Randomized Study Comparing the Efficacy and Safety of Intravenoous Ciproflaxacin with the
Standard Antibiotic Therapy in the Treatment of Selected Tissue Infections (Multi-Center)."
Study D90-034, Miles, Inc., Pharmaceutical Division, November 1990. Drug-Study Nurse Coordinator.
"Cefaclor A.F. vs. Cefalor in Various Bacterial Infections." Study B3M-M-AIKA, Eli Lilly & Company, January 1989.
Drug Study Nurse Coordinator.
"A Comparison of the Efficacy and Tolerance of Ventolon in Solution for Inhalation to Alupent Inhalant Solution to
Placebo in Home Nebulization in Adults with Chronic Obstructive Pulmonary Disease." Glaxo Pharmaceuticals
, April 1988. Drug Study Nurse Coordinator.
"A Double-Blind Multicenter Group Comparative Study of the Efficacy and Safety of Tilade BID (Nedocromil Sodium
) vs. Placebo in the Management of Adults with Reversible Airway Obstruction. " Study 87-11A, Fisons,
November 1987. Drug Study Nurse Coordinator.
"A Double-Blind Multicenter Group Comparative Study of the Efficacy and Safety of Tilade (Nedocromil Sodium
) vs. Placebo in the Management of Adults with Reversible Airway Obstruction. " Study 87-11, Fisons,
November 1987. Drug Study Nurse Coordinator.
"A Multinational Multicenter, Double-Blind, Placebo-Controlled
Phase III Study of Evaluate the Efficacy and Safety of Aerosolized Recominant Human
Dnase I in Hospitalized Patients with Chronic Obstructive Pulmanary Exacerbation."
GNE610g-A1. Genetech, June 1994. Drug Study Nurse Coordinator.
